John Libbey Eurotext

Bulletin du Cancer


News in the medical treatment of breast cancer Volume 90, issue 1, Janvier 2003


See all figures

Unité de chimiothérapie, Institut Jules-Bordet, 1, rue Heger-Bordet, 1000 Bruxelles, Belgique

During the last decade, except for breast cancer, few " solid " tumours have benefited from significant progress in systemic treatment able to reduce the progression of metastases in advanced disease or to eradicate possible micro-metastases in the adjuvant situation. This review aims to guide the reader along the paths of the progress made in hormonotherapy, chemotherapy and targeted molecular therapy. For each category, the authors will attempt to estimate the impact of the therapeutic advances upon day-to-day clinical practice.